Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 2 1Phase 1 1

Status

Completed 3Recruiting 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

CNS 4Sarcoma 2

Conditions

Lung Neoplasms 4Head and Neck Neoplasms 4Glioblastoma 4Breast Neoplasms 4Sarcoma 3Pancreatic Neoplasms 3Glioma 3Brain Neoplasms 3Virus Diseases 2Urinary Bladder Neoplasms 2Stomach Neoplasms 2Ovarian Neoplasms 2Neuroectodermal Tumors 2Nervous System Diseases 2Neoplasms, Neuroepithelial 2Neoplasms, Nerve Tissue 2Neoplasms 2Melanoma 2Liver Neoplasms 2Gliosarcoma 2Colorectal Neoplasms 2Carcinoma 2Uterine Cervical Neoplasms 1Small Cell Lung Carcinoma 1Pharyngeal Neoplasms 1Otorhinolaryngologic Neoplasms 1Nose Neoplasms 1Neoplasms, Glandular and Epithelial 1Neoplasms, Germ Cell and Embryonal 1Neoplasms by Histologic Type 1

Interventions

Temozolomide 393Radiotherapy 196Bevacizumab 156Radiation 77Magnetic Resonance Spectroscopy 68Lomustine 47Surgical Procedures, Operative 42Carmustine 41pembrolizumab 39Irinotecan 38Nivolumab 32Specimen Handling 27Carboplatin 27Radiosurgery 24Erlotinib Hydrochloride 24Chemotherapy, Adjuvant 23Radiotherapy, Intensity-Modulated 22Drug Therapy 21Cyclophosphamide 20Aminolevulinic Acid 20O(6)-benzylguanine 17sargramostim 16Radiotherapy, Conformal 15temsirolimus 14Granulocyte-Macrophage Colony-Stimulating Factor 14Everolimus 14Vorinostat 13Sorafenib 13poly ICLC 12atezolizumab 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Glioblastoma × Oncolytic Virotherapy × Clear all
NCT07145047 2025-12-19

Clinical Study of Oncolytic Virus in Glioblastoma

Mianyang Central Hospital

Phase 1/2 Recruiting
20 enrolled
CNS

Glioblastoma

NCT06562621 2024-08-20

Clinical Study on the Safety and Efficacy of Novel Oncolytic Virus in the Treatment of Recurrent Malignant Glioma

Beijing Neurosurgical Institute

Phase 1/2 Completed
38 enrolled
CNS

Glioblastoma, Glioma

NCT02798406 2021-07-15

CAPTIVE

DNAtrix, Inc.

Phase 2 Completed
49 enrolled
CNSSarcoma

Brain Neoplasms, Disease, Glioblastoma, Glioma, Neoplasms, Neoplasms, Nerve Tissue, Nervous System Diseases, Neuroectodermal Tumors, Neoplasms, Neuroepithelial, Gliosarcoma

NCT02197169 2018-07-16

TARGET-I

DNAtrix, Inc.

Phase 1 Completed
37 enrolled
CNSSarcoma

Brain Neoplasms, Central Nervous System Diseases, Glioblastoma, Glioma, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Glandular and Epithelial, Neoplasms, Nerve Tissue, Nervous System Diseases, Central Nervous System Neoplasms, Neuroectodermal Tumors, Neoplasms, Neuroepithelial, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡